Management of infants with bronchopulmonary dysplasia in Germany

Area of Science:

• Neonatology
• Pediatric Pulmonology

Background:

• Official guidelines for bronchopulmonary dysplasia (BPD) diagnosis and treatment in Germany are not uniformly applied in tertiary care centers.
• Significant variation exists in clinical practice regarding BPD management.

Purpose of the Study:

• To highlight discrepancies in BPD care practices within German neonatology centers.
• To provide recommendations on oxygen saturation targets and therapeutic interventions for BPD.

Main Methods:

• Review of current practices and guidelines for BPD management.
• Analysis of expert opinions on oxygen saturation targets and pharmacological interventions.

Main Results:

• No consensus exists on optimal oxygen saturation levels for infants at risk for or with established BPD.
• A target oxygen saturation just below 90% initially, and in the lower nineties thereafter, is proposed.
• Restrictive use of systemic corticosteroids is advised due to adverse outcomes.
• Diuretics, inhaled corticosteroids, and bronchodilators should be used selectively based on individual response, not routinely.
• Domiciliary oxygen therapy, though rarely used in Germany, is safe and effective when well-organized, requiring close follow-up.

Conclusions:

• Clinical practice for BPD in Germany shows considerable variation.
• Recommendations include specific oxygen saturation targets and cautious use of medications.
• Domiciliary oxygen therapy is a viable option requiring careful planning and monitoring.